Patents by Inventor SANDEEP PAL

SANDEEP PAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230241036
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: February 27, 2023
    Publication date: August 3, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230218586
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: February 27, 2023
    Publication date: July 13, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20230046943
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Sandeep PAL
  • Oral pharmaceutical composition comprising zonisamide and process of preparation thereof
    Patent number: 11529333
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: December 20, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof
    Patent number: 11478456
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Grant
    Filed: March 15, 2022
    Date of Patent: October 25, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • PYRIDYL OR PYRIMIDYL MTOR KINASE INHIBITORS
    Publication number: 20220306623
    Abstract: The invention relates to compounds or pharmaceutically acceptable salts thereof of formula (I): wherein R1, R2, R3, R4, R4? and R5 are as defined in the description and claims; and compounds or pharmaceutically acceptable salts thereof of formulas (II), (IIa), (IIb), (IIc), and (III) having mTOR kinase inhibitor activity. The invention also relates to pharmaceutical compositions which include a compound of formula (I), (II), (IIa), (IIb), (IIc), or (III) or a pharmaceutically acceptable salt thereof, and to the use of a compound of formula (I), (II), (IIa), (IIb), (IIc), or (III), or a pharmaceutically acceptable salt thereof in therapy, including in the treatment of a disease or condition for which an mTOR kinase inhibitor activity is indicated, and in particular the treatment of idiopathic pulmonary fibrosis.
    Type: Application
    Filed: June 11, 2020
    Publication date: September 29, 2022
    Inventors: Sophie Marie BERTRAND, Heather HOBBS, Simon Marc NICOLLE, Sandeep PAL, Simon PEACE, Margarita PUENTE-FELIPE
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20220202782
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: March 15, 2022
    Publication date: June 30, 2022
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Workload Behavior Modeling and Prediction for Data Center Adaptation
    Publication number: 20170286252
    Abstract: Examples may include techniques to a indicate behavior of a data center. A data center is monitored to collect operating information and one or more models to represent behavior of the data center are built based on the collected operating information. Predicted behavior of the data center to support a workload based on different operating scenarios using the one or more built models is indicated to facilitate resource allocation and scheduling for the workload supported by the data center.
    Type: Application
    Filed: April 1, 2016
    Publication date: October 5, 2017
    Inventors: RAMESHKUMAR G. ILLIKKAL, SAJAN K. GOVINDAN, DEEPTHI KARKADA, SANDEEP PAL, PATRICK J. HOLMES